BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37591832)

  • 21. A/C Simultaneous Conversion Using the Dual Base Editor in Human Cells.
    Zhang X; Guan Y; Li D
    Methods Mol Biol; 2023; 2606():63-72. PubMed ID: 36592308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR/Cas-Mediated Base Editing: Technical Considerations and Practical Applications.
    Molla KA; Yang Y
    Trends Biotechnol; 2019 Oct; 37(10):1121-1142. PubMed ID: 30995964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TadA orthologs enable both cytosine and adenine editing of base editors.
    Zhang S; Yuan B; Cao J; Song L; Chen J; Qiu J; Qiu Z; Zhao XM; Chen J; Cheng TL
    Nat Commun; 2023 Jan; 14(1):414. PubMed ID: 36702837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Replacing the
    Villiger L; Schmidheini L; Mathis N; Rothgangl T; Marquart K; Schwank G
    Mol Ther Nucleic Acids; 2021 Dec; 26():502-510. PubMed ID: 34631280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling pancreatic pathophysiology using genome editing of adult stem cell-derived and induced pluripotent stem cell (iPSC)-derived organoids.
    Hirshorn ST; Steele N; Zavros Y
    Am J Physiol Gastrointest Liver Physiol; 2021 Jun; 320(6):G1142-G1150. PubMed ID: 33759566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of an Efficient C-to-T Base-Editing System and Its Application to Cellulase Transcription Factor Precise Engineering in Thermophilic Fungus
    Zhang C; Li N; Rao L; Li J; Liu Q; Tian C
    Microbiol Spectr; 2022 Jun; 10(3):e0232121. PubMed ID: 35608343
    [No Abstract]   [Full Text] [Related]  

  • 27. Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors.
    Grünewald J; Zhou R; Garcia SP; Iyer S; Lareau CA; Aryee MJ; Joung JK
    Nature; 2019 May; 569(7756):433-437. PubMed ID: 30995674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual base editor catalyzes both cytosine and adenine base conversions in human cells.
    Zhang X; Zhu B; Chen L; Xie L; Yu W; Wang Y; Li L; Yin S; Yang L; Hu H; Han H; Li Y; Wang L; Chen G; Ma X; Geng H; Huang W; Pang X; Yang Z; Wu Y; Siwko S; Kurita R; Nakamura Y; Yang L; Liu M; Li D
    Nat Biotechnol; 2020 Jul; 38(7):856-860. PubMed ID: 32483363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR-CBEI: a Designing and Analyzing Tool Kit for Cytosine Base Editor-Mediated Gene Inactivation.
    Yu H; Wu Z; Chen X; Ji Q; Tao S
    mSystems; 2020 Sep; 5(5):. PubMed ID: 32963098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Base Editing: The Ever Expanding Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Tool Kit for Precise Genome Editing in Plants.
    Monsur MB; Shao G; Lv Y; Ahmad S; Wei X; Hu P; Tang S
    Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32344599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increasing the Targeting Scope of CRISPR Base Editing System Beyond NGG.
    Yu SY; Birkenshaw A; Thomson T; Carlaw T; Zhang LH; Ross CJD
    CRISPR J; 2022 Apr; 5(2):187-202. PubMed ID: 35238621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling Wnt signaling by CRISPR-Cas9 genome editing recapitulates neoplasia in human Barrett epithelial organoids.
    Liu X; Cheng Y; Abraham JM; Wang Z; Wang Z; Ke X; Yan R; Shin EJ; Ngamruengphong S; Khashab MA; Zhang G; McNamara G; Ewald AJ; Lin D; Liu Z; Meltzer SJ
    Cancer Lett; 2018 Nov; 436():109-118. PubMed ID: 30144514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation and immunofluorescent validation of gene knockouts in adult human colonic organoids using multi-guide RNA CRISPR-Cas9.
    Chan DKH; Collins SD; Buczacki SJA
    STAR Protoc; 2023 Mar; 4(1):101978. PubMed ID: 36598849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Base editors for simultaneous introduction of C-to-T and A-to-G mutations.
    Sakata RC; Ishiguro S; Mori H; Tanaka M; Tatsuno K; Ueda H; Yamamoto S; Seki M; Masuyama N; Nishida K; Nishimasu H; Arakawa K; Kondo A; Nureki O; Tomita M; Aburatani H; Yachie N
    Nat Biotechnol; 2020 Jul; 38(7):865-869. PubMed ID: 32483365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted Mutagenesis in Mice Using a Base Editor.
    Jeong TY; Lim SY; Seong JK; Kim K
    Methods Mol Biol; 2023; 2606():99-119. PubMed ID: 36592311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recent advances and applications of base editing systems].
    Xu X; Liu M
    Sheng Wu Gong Cheng Xue Bao; 2021 Jul; 37(7):2307-2321. PubMed ID: 34327897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing.
    Chadwick AC; Wang X; Musunuru K
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1741-1747. PubMed ID: 28751571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BEAR reveals that increased fidelity variants can successfully reduce the mismatch tolerance of adenine but not cytosine base editors.
    Tálas A; Simon DA; Kulcsár PI; Varga É; Krausz SL; Welker E
    Nat Commun; 2021 Nov; 12(1):6353. PubMed ID: 34732717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [CRISPR/Cas-mediated DNA base editing technology and its application in biomedicine and agriculture].
    Yu C; Mo J; Zhao X; Li G; Zhang X
    Sheng Wu Gong Cheng Xue Bao; 2021 Sep; 37(9):3071-3087. PubMed ID: 34622618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A dual-deaminase CRISPR base editor enables concurrent adenine and cytosine editing.
    Grünewald J; Zhou R; Lareau CA; Garcia SP; Iyer S; Miller BR; Langner LM; Hsu JY; Aryee MJ; Joung JK
    Nat Biotechnol; 2020 Jul; 38(7):861-864. PubMed ID: 32483364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.